To solve the puzzle of what is wrong with some very ill newborns, clinicians are beginning to turn to genome sequencing. A team at Children's Mercy Hospital in Kansas City recently used sequencing information to figure out what was going on with a baby girl who wasn't eating or growing, reports Susan Young at Technology Review.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.